Sign up
Pharma Capital

PreveCeutical Medical Inc. receives first cannabis shipment at Australia lab

PreveCeutical Medical Inc. (CSE:PREV, OTCMKTS:PRVCF) CEO Stephen Van Deventer tells Proactive Investors the health sciences company received its first shipment of dried cannabis flowers and oils from Aurora Cannabis to their lab in Australia.

Van Deventer says PreveCeutical are now profiling three different cannabis strains for the application of soluble gel (Sol-gel) drug-delivery technology to cannabinoids. Van Deventer says it will take about 18 months until a product is available.


View full PREV profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.